Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths, and current treatments, while effective, can be physically taxing or have adverse effects. Adipose-derived stem cells (ADSCs) offer a promising alternative due to their easy extraction and unique immunomodulatory properties. These cells produce factors that can influence tumor growth, but their effects on cancer cells, including HCC, are not yet clear, showing both inhibitory and stimulatory outcomes. The review highlights the need for further research to understand the potential of ADSCs in treating HCC, as current evidence from preclinical and clinical studies is inconclusive.